PUBLICATION

A noncanonical IRAK4-IRAK1 pathway counters DNA damage-induced apoptosis independently of TLR/IL-1R signaling

Authors
Li, Y., Shah, R.B., Sarti, S., Belcher, A.L., Lee, B.J., Gorbatenko, A., Nemati, F., Yu, H., Stanley, Z., Rahman, M., Shao, Z., Silva, J.M., Zha, S., Sidi, S.
ID
ZDB-PUB-231220-6
Date
2023
Source
Science signaling   16: eadh3449eadh3449 (Journal)
Registered Authors
Sidi, Samuel
Keywords
none
MeSH Terms
  • Animals
  • Apoptosis
  • DNA Damage
  • Humans
  • Interleukin-1 Receptor-Associated Kinases*/genetics
  • Interleukin-1 Receptor-Associated Kinases*/metabolism
  • Receptors, Interleukin-1*/genetics
  • Receptors, Interleukin-1*/metabolism
  • Signal Transduction
  • Toll-Like Receptors/metabolism
  • Zebrafish/metabolism
PubMed
38113335 Full text @ Sci. Signal.
Abstract
Interleukin-1 receptor (IL-1R)-associated kinases (IRAKs) are core effectors of Toll-like receptors (TLRs) and IL-1R in innate immunity. Here, we found that IRAK4 and IRAK1 together inhibited DNA damage-induced cell death independently of TLR or IL-1R signaling. In human cancer cells, IRAK4 was activated downstream of ATR kinase in response to double-strand breaks (DSBs) induced by ionizing radiation (IR). Activated IRAK4 then formed a complex with and activated IRAK1. The formation of this complex required the E3 ubiquitin ligase Pellino1, acting structurally but not catalytically, and the activation of IRAK1 occurred independently of extracellular signaling, intracellular TLRs, and the TLR/IL-1R signaling adaptor MyD88. Activated IRAK1 translocated to the nucleus in a Pellino2-dependent manner. In the nucleus, IRAK1 bound to the PIDD1 subunit of the proapoptotic PIDDosome and interfered with platform assembly, thus supporting cell survival. This noncanonical IRAK signaling pathway was also activated in response to other DSB-inducing agents. The loss of IRAK4, of IRAK4 kinase activity, of either Pellino protein, or of the nuclear localization sequence in IRAK1 sensitized p53-mutant zebrafish to radiation. Thus, the findings may lead to strategies for overcoming tumor resistance to conventional cancer treatments.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping